{"name":"NP Therapeutics","slug":"np-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTE9MeDdPbV9Md01YektGbElJdXZMUVFtRVRIMHJoLW53VE9yQThiLVlWUGg2N0p0bVNNaFBTdkJKdU5zYldYQklwQklqempfaXl6ampiMg?oc=5","date":"2026-04-01","type":"pipeline","source":"BC government","summary":"PharmaCare Newsletter - BC government","headline":"PharmaCare Newsletter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE9TWlJRNUpaVlM2MFcwTlhuQ04tQnZtNHhtekk2Z2twTWFWTmxmcWNicmptY0RWam1INFJ4UUwwTEktbDBpbmJvVzRZZTVJRlJvVjNlcGMxbEs0VlhxdWxnQw?oc=5","date":"2026-02-26","type":"pipeline","source":"BC Gov News","summary":"Enhancing drug coverage for people in British Columbia - BC Gov News","headline":"Enhancing drug coverage for people in British Columbia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPcl9tTjF1TTZyWldmbFZERVE2YVVHcTFEbXhPM29XVGRpSnVUOGlTYVotc3RseVU2WW9yYmZ5UWVJeFUzN1E2RkhESlktZUZZSno2eDBNQ2VfQjE4ckxRRjNqdzV5aWhPZ2tvUlBuOHpyOXNNNVhWUk5wbndoRlFDTHhUWWpEX3RRUzR6eUloR1lhSU1FcmFDUG1JbzVQQQ?oc=5","date":"2026-01-27","type":"regulatory","source":"OncLive","summary":"NP-G1-044 Receives FDA Orphan Drug Designation for Pancreatic Cancer - OncLive","headline":"NP-G1-044 Receives FDA Orphan Drug Designation for Pancreatic Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxPcWRYaVpuMVFqN1piRE52MU5jLVZzWTVIcW5lY3o5dXg0UzlkZzM0Uy1qYlIwalNuUUx0WXBpRnN3YmFZaUxfSWdxMnV4UGxraUlpNmpiZEw1TmZYMHlacWhYQ2hXRnduYUt4aGxMMkp0OUFNbkd5N0NKMUJFSDV3SkZnck9ia0g3UFdncERnR2NpeTVERzgwWFNtS21IcXBWS21LSG1RTlZWTDhRMkdoR3Y4T0haRU1kMld0cVhWaDVPWkpqb1NRTFFXWHdSOHc1NFYyWkgyaDgzNVRDclRMX2ZmeVh1c0lOaWFXM2RaNXFZMjRPOGRhdElZR1Jta2c4UnhSV2hQVQ?oc=5","date":"2026-01-12","type":"regulatory","source":"PR Newswire","summary":"Novita Pharmaceuticals Announces FDA Orphan Drug Designation Granted to NP-G2-044 for the Treatment of Pancreatic Cancer - PR Newswire","headline":"Novita Pharmaceuticals Announces FDA Orphan Drug Designation Granted to NP-G2-044 for the Treatment of Pancreatic Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNdHl1ejR3RjRtb3Y3OVI3cmpMTFctSDVXcGNiUUpkREJSbFh5T09mY3ZzUm1TZGgtZFhXckdURXpRZC1rQUlGa2tQdVFhVVFHNEpzRDVEZDV6QzU2Yy05eDhYOUUzYzB5YkZVZ2RTN1JJUTE0aGNwVUVmazNnbzhtR2k5NHNsejRfWGJEUjFhTVRnc0xRZFRRTEQ4V1BzMGdJa1E?oc=5","date":"2026-01-12","type":"regulatory","source":"Targeted Oncology","summary":"FDA Orphan Drug Designation Given to NP-G2-044 in Pancreatic Cancer - Targeted Oncology","headline":"FDA Orphan Drug Designation Given to NP-G2-044 in Pancreatic Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE4tVFZXN3BDOXNLd0R4V2RoX09kaTNzN2g1ci02TTRHbWFnLWZkQ3RJZHI2Ykc4MGl0NjhpYTNGWGZoemFjQXA1eFVvZDJMUjhHTGNj?oc=5","date":"2025-10-06","type":"pipeline","source":"FirstWord Pharma","summary":"NanoPhoria nabs €83.5M for inhaled heart failure therapy - FirstWord Pharma","headline":"NanoPhoria nabs €83.5M for inhaled heart failure therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOLUJ4MnhPWkY0NGlXbF8zYnR5YWtRQklyZXNZLUpfUGthNWI2dnpsZlU4TnM3RjFQTnB2U3E5Vy03bW82UkNGb0tSUGlpYTloMlF5a0lUaWE1Q0hjS3R4eVVTSXN5Y1VzM1ZvcHFhdEpBLUNlaF9vSmNIb0F6bU9UM0R4OFVWSFZORFI0LXZCRzlVLTNsVlRFVzZ2YjY?oc=5","date":"2025-09-15","type":"pipeline","source":"HCPLive","summary":"Navigating New PBC Therapies and Treatment Monitoring With Ann Moore, NP - HCPLive","headline":"Navigating New PBC Therapies and Treatment Monitoring With Ann Moore, NP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAJBVV95cUxPOEFiTWQ0cTVxa05QSHlDMzN4ZjJxVWxCVXRKZmtod0tHSTY3X2M3ZC1sSkRMQ2lfRWFMVmx5TnY1OWZkemY2S19kb3pBdXpDRmZ3N0QwN0FQWEtTcWM2YXc5cC1sV0ZOWGNkX19SaF9tR2doOWRBUEFXR3VPeDNQRXVnWTMxWWN1Z20ya0ZpV19xU1ZrM0pvWEF0VHEtMDZmaVlyVlhZT0ctVG9vQ0tRMEdVQVhLN3hrTDhUWDBOWkFCb2o4c2hRVVRyWnlEd2VVV2xvRnpveXNDVS02RlV0dEU5VXpadmlCNUlUOWxXZVozX0E2aXNyNG5JWDZBbjdrZi13T3FMMzZhbGlVYzU3c0N5RVo4RmJRM1Y2T1dNc2xzYjIxdWFKcw?oc=5","date":"2025-05-22","type":"trial","source":"PR Newswire","summary":"Novita Highlights Positive Data from Phase 2 Trial of NP-G2-044 in Patients with Advanced and Metastatic Solid Tumors at 2025 ASCO Annual Meeting - PR Newswire","headline":"Novita Highlights Positive Data from Phase 2 Trial of NP-G2-044 in Patients with Advanced and Metastatic Solid Tumors at","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxQNXh2Q0lsZmFGSzdzdklGQ3VHaGJFYXVOUWFwaEZDeUwycVpUaVY4ZmhrekdOeTU5WGtQUWhPQk1TNEFFNk93N2d0NGMxRXdkVGpGSHpRMmFpTVpOSHF1WXRpLWJmbFpERzN3TTBpVmg2ZWZwYWtScUFsS3RHd0ZQMUlHYw?oc=5","date":"2025-04-25","type":"regulatory","source":"The Pharma Letter","summary":"FDA approves penpulimab-kcqx for NP carcinoma - The Pharma Letter","headline":"FDA approves penpulimab-kcqx for NP carcinoma","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNZGhHWDk0LU9Lb3Z2aXBudF9hekRwY2FITklQaEkwblptZ09fRHRPTFdpYkkwa09SaVBMa0ljdzM1bXd0c2tzdEFVQ3QwNjNPN1lNR1lsa1lpYzU2cjZRYm42U1V6QUVYS3BUYTFjTXhJRExsblBOczE1MTNHTW9YamxjM25YOVBtU2tVOQ?oc=5","date":"2025-03-25","type":"pipeline","source":"Medical Marketing and Media","summary":"Changing the game in NP and PA engagement - Medical Marketing and Media","headline":"Changing the game in NP and PA engagement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOMVBZdXlrYjhMRGo5ZnhDUzRNZDFwMHZBaUlYb0FVZGYwSmtpN1AyLWJwTVNzaGpLcW9zZ29BUWZ6NDNhVGw1VnlmSjAyTkVNLTFvZVBOc0pTTWdSX01Mb1BlWmNpLVlqQVBPbzBZSWFBZTlsMmk1Wkp2RG9rZFRDTm55U2VLdmdNZ3BxVlVBZ0Mya0M3ZE1LWng5a3JRMGMwMFZIcTR2ZGE3YmdSUjBnOWlJRQ?oc=5","date":"2024-10-07","type":"pipeline","source":"Pharmaceutical Technology","summary":"Neuvivo makes bid to enter ALS arena with immunotherapy candidate - Pharmaceutical Technology","headline":"Neuvivo makes bid to enter ALS arena with immunotherapy candidate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPRVRvU0tXVTBDbmJaTk9RQWw5eWhOQnVOVWVTcjBFWlBBd0xmMVpIamVvb0pFcXJUX3BuQTE5YlY4NlhyRVUyRlVaWHRnZWlNZ2tZRmVqT0ZLc0N5dU55Vm5GT0tzSHFQZzI3VllLX2hrZ3pkZ1lLVVI0REpiNi1ORkxmM18yVUE5dXJhdDBBZU9YbjEw?oc=5","date":"2024-08-27","type":"regulatory","source":"Frontiers","summary":"Advances in research on potential therapeutic approaches for Niemann-Pick C1 disease - Frontiers","headline":"Advances in research on potential therapeutic approaches for Niemann-Pick C1 disease","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}